Synthesis, pharmacological effects, and conformation of 4,4-disubstituted 1,4-dihydropyridines

Journal of Medicinal Chemistry
1990.0

Abstract

4,4-Disubstituted 1,4-dihydropyridines are synthesized by intramolecular addition of sulfinyl carbanions to pyridines. These disubstituted derivatives show a loss of Ca antagonistic potency of up to three powers of 10 both in vitro on aortic rings and in vivo on anaesthetized dogs as compared to examples that are monosubstituted at the 4-position of the DHP ring. As the X-ray structure shows, the 4-aryl substituent is present not in the accustomed axial conformation, but in an equatorial one. This dramatic change in conformation could be the reason for the major loss of activity and would indicate the need for axial conformation of the aryl residue in pharmacologically active 1,4-dihydropyridines. The change in conformation was also confirmed by quantum chemical calculations (AM1).

Knowledge Graph

Similar Paper

Synthesis, pharmacological effects, and conformation of 4,4-disubstituted 1,4-dihydropyridines
Journal of Medicinal Chemistry 1990.0
Studies directed toward ascertaining the active conformation of 1,4-dihydropyridine calcium entry blockers
Journal of Medicinal Chemistry 1988.0
Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 3-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4-dihydropyridine
Journal of Medicinal Chemistry 1982.0
Synthesis of a New Series of 4-Aryl-1,4-Dihydropyridines with Calcium Channel Blocking and Vasodilatory Activity
Medicinal Chemistry Research 2012.0
Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine
Journal of Medicinal Chemistry 1980.0
1,4-Dihydropyridine antagonist activities at the calcium channel: a quantitative structure-activity relationship approach
Journal of Medicinal Chemistry 1988.0
Synthesis, calcium-channel blocking activity, and conformational analysis of some novel 1,4-dihydropyridines: application of PM3 and DFT computational methods
Medicinal Chemistry Research 2012.0
Synthesis and calcium channel antagonist activity of dialkyl 4-(dihydropyridinyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylates
Journal of Medicinal Chemistry 1987.0
Antihypertensive dihydropyridines with 1,4,4-trisubstitution
Journal of Medicinal Chemistry 1990.0
Long-acting dihydropyridine calcium antagonists. 6. Structure-activity relationships around 4-(2,3-dichlorophenyl)-3-(ethoxycarbonyl)-2-[(2-hydroxyethoxy)methyl]-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridine
Journal of Medicinal Chemistry 1991.0